 VICTORIA, British Columbia--BUSINESS WIRE--- IPA AI--IPA IMMUNOPRECISE ANTIBODIES LTD. the Company or IPA NASDAQ: IPA TSXV: IPA, an advanced biotherapeutic research and technology company, today announced that it will host a conference call to discuss its quarterly results and recent business highlights for first quarter fiscal year 2023, on Wednesday, September 14, 2022, at 10:30 am Eastern Time. The financial results will be issued in a press release prior to the call. ImmunoPrecise manag 